documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

17 rows where agency_id = "FDA", document_type = "Rule" and posted_year = 2006 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: docket_id, title, subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 1

  • 2006 · 17 ✖

document_type 1

  • Rule · 17 ✖

agency_id 1

  • FDA · 17 ✖
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2004-E-0268-0004 FDA Patent Extension for ERTACZO (sertaconazole nitrate), U.S. Patent No. 5,135,943 FDA-2004-E-0268 Certificate Extending Patent Term from U.S. Patent and Trademark Office to Birch, Stewart, Kolash & Birch, LLP Rule Certificate Extending Patent Term 2006-11-22T05:00:00Z 2006 11     2025-11-13T00:24:57Z   0 0 09000064804721ed
FDA-2001-E-0025-0002 FDA Patent Term Extension Application, PAYLEAN No. 4,690,951 FDA-2001-E-0025 U.S. Patent and Trademark Office Rule CEP-Certificate Extending Patent Term 2006-09-15T04:00:00Z 2006 9     2008-04-25T01:57:31Z   0 0 09000064804b59db
FDA-2002-E-0121-0005 FDA Patent Term Application for ATS Open Pivot Bileaf Valve 5,35, U.S. Patent No. 5,354,330 FDA-2002-E-0121 Letter from U.S. Patent and Trademark Office to Haugen Law Firm PLLP Rule Certificate Extending Patent Term 2006-09-15T04:00:00Z 2006 9     2025-10-08T17:00:29Z   0 0 090000648049044a
FDA-2001-E-0186-0002 FDA Patent Term Extension Application, Precedex No. 4,910,214 FDA-2001-E-0186 U.S. Patent and Trademark Office Rule CEP-Certificate Extending Patent Term 2006-09-15T04:00:00Z 2006 9     2008-04-25T02:26:00Z   0 0 09000064804e2087
FDA-2003-E-0221-0005 FDA Patent Extension for FACTIVE, gemifloxacin mesylate, #5,776,944 FDA-2003-E-0221 Certificate Extending Patent Term from U.S. Patent and Trademark Office to Finnegan, Henderson, Farabow, Garrett & Dunner. L.L.P. Rule Certificate Extending Patent Term 2006-09-15T04:00:00Z 2006 9     2025-10-30T19:44:54Z   0 0 090000648048cf06
FDA-2003-E-0327-0003 FDA Patent Term Extension Application for ZETIA No. RE37,721 FDA-2003-E-0327 Letter from U.S. Patent and Trademark Office to Sobering Corporation, Patent Department Rule Certificate Extending Patent Term 2006-09-15T04:00:00Z 2006 9     2025-10-22T16:57:46Z   0 0 090000648049589c
FDA-2000-E-1543-0002 FDA Patent Extension for Betaxon, No. 4,911,920 FDA-2000-E-1543 Certificate Extending Patent Term from U.S. Patent and Trademark Office Rule Certificate Extending Patent Term 2006-09-15T04:00:00Z 2006 9     2025-10-23T18:41:17Z   0 0 09000064804f9093
FDA-2003-E-0114-0007 FDA Zelnorm (Tegaserod Maleate), Patent Term Extension Application, U.S. Patent No. 5,510,353 FDA-2003-E-0114 Certificate Extending Patent Term from U.S. Patent and Trademark Office to Novartis Rule Certificate Extending Patent Term 2006-09-15T04:00:00Z 2006 9     2025-10-31T09:00:07Z   0 0 0900006480485158
FDA-2000-E-0238-0003 FDA Patent Extension Rapamune (sirolimus), #5,100,899 FDA-2000-E-0238 Certificate Extending Patent Term from U.S. Patent and Trademark Office Rule Certificate Extending Patent Term 2006-09-15T04:00:00Z 2006 9     2025-06-30T23:01:23Z   0 0 09000064804d59b0
FDA-2001-E-0079-0002 FDA Menicon Z Rigid Contact Lens, Patent Extension Application FDA-2001-E-0079 Certificate Extending Patent Term from U.S. Patent and Trademark Office Rule Certificate Extending Patent Term 2006-09-15T04:00:00Z 2006 9     2025-10-28T17:51:59Z   0 0 09000064804b83ca
FDA-1998-E-0082-0001 FDA Synvisc Hylan G_F20 Patent No. 5,143,724 FDA-1998-E-0082 Certificate Extending Patent Term from U.S. Patent and Trademark Office Rule Certificate Extending Patent Term 2006-09-15T04:00:00Z 2006 9     2025-02-24T20:04:40Z   0 0 09000064805849c9
FDA-2003-E-0325-0007 FDA Patent Term Restoration Application for Zubrin (tepoxalin), U.S. Patent No. 4,826,868 FDA-2003-E-0325 Certificate Extending Patent Term from U.S. Patent and Trademark Office to Johnson & Johnson Rule Certificate Extending Patent Term 2006-09-15T04:00:00Z 2006 9     2025-10-29T23:02:31Z   0 0 090000648049584d
FDA-2003-E-0066-0007 FDA Patent Extension, Neutersol, zinc gluconate, Patent No. 4,937,234 FDA-2003-E-0066 Certificate Extending Patent Term from U.S. Patent and Trademark Office to Grace J. Fishel Rule Certificate Extending Patent Term 2006-09-15T04:00:00Z 2006 9     2025-10-30T22:39:23Z   0 0 0900006480481c09
FDA-2003-N-0212-0001 FDA Medical Devices; Exception from General Requirements for Informed Consent FDA-2003-N-0212 Notice of Interim Rule re Medical Devices; Exception from General requirements for Informed Consent Rule Interim Final Rule 2006-06-08T04:00:00Z 2006 6 2006-06-06T04:00:00Z 2006-08-09T03:59:59Z 2015-12-07T16:12:36Z   0 0 090000648048c13a
FDA-2004-H-0391-0127 FDA Civil Money Penalty, Ecumed Health Group (EHG), Inc. FDA-2004-H-0391 Administrative Law Judge Rule IDF-Initial Decision by Admin Law Judge 2006-04-28T04:00:00Z 2006 4     2008-04-12T00:37:51Z   0 0 090000648047437a
FDA-2003-P-0346-0004 FDA 513(f) Reclassification Petition for In Vitro Diagnostics for Anti-Hepatitis A Virus IgM and Total Antibodies FDA-2003-P-0346 Final Rule; Correction Re: Microbiology Devices; Reclassification of Hepatitis, A Virus Serological Assays; Correction Rule NCR-Notice of Correction 2006-03-03T05:00:00Z 2006 3 2006-02-28T05:00:00Z 2006-05-02T03:59:59Z 2024-11-25T16:50:04Z 71FR10433 0 0 0900006480496e10
FDA-2003-P-0346-0003 FDA 513(f) Reclassification Petition for In Vitro Diagnostics for Anti-Hepatitis A Virus IgM and Total Antibodies FDA-2003-P-0346 Final Rule Re: Microbiology Devices; Reclassification of Hepatitis, A Virus Serological Assays Rule NFR-Notice of Final Rule 2006-02-10T05:00:00Z 2006 2 2006-02-08T05:00:00Z 2006-02-10T04:59:59Z 2024-11-25T16:45:55Z 71FR6677 0 0 0900006480496e0e

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);